Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Am J Cardiol ; 83(4): 592-6, A8, 1999 Feb 15.
Article in English | MEDLINE | ID: mdl-10073868

ABSTRACT

We studied the response of radial artery (RA) or left internal mammary artery grafts to the intraluminal infusion of serotonin in 22 consecutive patients 1 year after the operation, subsequently evaluating the effect of diltiazem in 9 patients. Serotonin causes a significant vasoconstriction of the RA grafts, but not of the left internal mammary artery grafts, whereas oral diltiazem treatment does not prevent the effect of the higher dose of serotonin on RA grafts.


Subject(s)
Coronary Disease/surgery , Coronary Vessels/physiology , Diltiazem/pharmacology , Free Radical Scavengers/pharmacology , Internal Mammary-Coronary Artery Anastomosis , Radial Artery/transplantation , Serotonin/pharmacology , Vasoconstriction/drug effects , Aged , Coronary Angiography , Coronary Disease/diagnostic imaging , Coronary Vessels/drug effects , Female , Humans , Isosorbide Dinitrate/pharmacology , Male , Middle Aged
2.
Am J Cardiol ; 82(11): 1323-8, 1998 Dec 01.
Article in English | MEDLINE | ID: mdl-9856913

ABSTRACT

A low heart rate variability (HRV) has been shown to be a powerful predictor of cardiac events in patients surviving an acute myocardial infarction (MI), but it is not clear yet which among the HRV parameters has the best predictive value. Time domain and frequency domain HRV was assessed on 24-hour predischarge Holter recording of 239 patients with a recent MI. Patients were followed up for 6 to 54 months (median 28), during which 26 deaths (11%) occurred, 19 of which were cardiac in origin and 12 were sudden. Most HRVs did not show any difference between patients with or without mortality end points, but the average low-frequency and low-frequency/high-frequency ratio was lower in patients with events. However, when dichotomized according to cut points that maximized the risk of sudden death, several HRVs were significantly predictive of clinical end points. Overall, the mean of the standard deviations of all RR intervals for all 5-minute segments and the standard deviation of the mean RR intervals for all 5-minute segments were the time domain variables most significantly associated with mortality end points, whereas very low frequency was the most predictive frequency domain variable. Compared with the best time domain variables, very low frequency showed a better sensitivity (0.27 to 0.42 vs 0.19 to 0.33) for end points with only a small loss in specificity (0.92 vs 0.96). On multivariate Cox proportional analysis, a left ventricular ejection fraction <40% and a number of ventricular premature beats > or = 10/hour were the most powerful independent predictors for all end points, whereas no HRV was independently associated with the events. A low frequency/high frequency ratio < 1.05 only had a borderline association with sudden death (RR = 2.86, p = 0.076). Our data show a strong association between HRV and mortality in patients surviving a recent MI, with a slight better sensitivity of frequency domain analysis. In our study, however, HRV did not add independent prognostic information to more classic prognostic variables (e.g., left ventricular function and ventricular arrhythmias).


Subject(s)
Heart Rate , Myocardial Infarction/mortality , Aged , Analysis of Variance , Death, Sudden, Cardiac , Electrocardiography, Ambulatory , Female , Follow-Up Studies , Humans , Male , Middle Aged , Myocardial Infarction/physiopathology , Predictive Value of Tests , Prognosis , Stroke Volume
3.
Case Rep Vasc Med ; 2013: 639384, 2013.
Article in English | MEDLINE | ID: mdl-24106639

ABSTRACT

Spontaneous coronary artery dissection (SCAD) is a rare, complex disease, nowadays poorly understood yet. The lack of firm recommendations about this issue is a great limitation which makes any therapeutic decision controversial. The case described is that of a young, otherwise healthy woman, who presented with an ostial dissection of the left anterior descending (LAD) artery. Due to patient's stable clinical and hemodynamic parameters, we used a cautious approach based on watchful waiting and medical therapy, postponing stenting in order to achieve a partial vessel reopening with a more comfortable access to PCI.

4.
J Endocrinol Invest ; 27(5): RC8-11, 2004 May.
Article in English | MEDLINE | ID: mdl-15279069

ABSTRACT

UNLABELLED: The ability of acute rosiglitazone administration in influencing ACTH/cortisol secretion in basal conditions and after CRH stimulation was studied in patients with Cushing's disease. Ten patients (8 women and 2 men, aged 18-65 yr) with Cushing's disease were enrolled in the study: 6 of them had previously undergone unsuccessful surgery and 4 were untreated. Plasma ACTH and serum cortisol levels were evaluated at serial time points for 3 h during saline infusion and after the administration of rosiglitazone (8 mg, po) and for 1 h after the injection of CRH (1 microg/kg iv) given alone or 30 min following rosiglitazone administration. The 4 tests were performed in all subjects in randomized order on different days. No significant difference was observed between the pattern of hormone secretion during saline alone and after rosiglitazone, as evaluated by two-way analysis of variance (ANOVA). The integrated areas under the curves (AUCs) were also not significantly different (ACTH: 5683 +/- 1038 vs 6111 +/- 1007 pg/ml/180 min; cortisol: 2333 +/- 267 vs 2902 +/- 486 microg/dl/180 min). In addition, there was no difference for ACTH and cortisol responses to CRH given either alone or after rosiglitazone, when evaluated as peak, increment or AUC; the pattern of the responses analyzed by two-way ANOVA was also similar. IN CONCLUSION: 1) the administration of a single dose of rosiglitazone did not decrease ACTH/cortisol levels or blunt their response after CRH injection; 2) the activation of PPAR-gamma receptors by rosiglitazone seems unable to affect ACTH and cortisol secretion, at least in acute conditions, in patients with ACTH-secreting pituitary adenomas.


Subject(s)
Adrenocorticotropic Hormone/blood , Corticotropin-Releasing Hormone/pharmacology , Hypoglycemic Agents/pharmacology , Pituitary ACTH Hypersecretion/blood , Thiazolidinediones/pharmacology , Adolescent , Adrenocorticotropic Hormone/metabolism , Adult , Aged , Female , Humans , Hydrocortisone/blood , Hydrocortisone/metabolism , Hydrocortisone/urine , Ligands , Male , Middle Aged , PPAR gamma/metabolism , Pituitary ACTH Hypersecretion/drug therapy , Pituitary ACTH Hypersecretion/urine , Rosiglitazone
SELECTION OF CITATIONS
SEARCH DETAIL